جرعات لقاح كورونا. الأسئلة الشائعة حول لقاح كورونا (كوفيد١٩)

Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U Centers for Disease Control and Prevention
FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine

الأسئلة الشائعة حول لقاح كورونا (كوفيد١٩)

Centers for Disease Control and Prevention.

3
الأسئلة الشائعة حول لقاح كورونا (كوفيد١٩)
Centers for Disease Control and Prevention
لقاح كورونا
Phased allocation of COVID-19 vaccines
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
V-safe after vaccination health checker
COVID-19 vaccines vs variants — Determining how much immunity is enough Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents
Vaccination considerations for persons with underlying medication conditions Morbidity and Mortality Weekly Report

لقاح كورونا

Officials discuss COVID-19 vaccine deliveries prioritization criteria.

18
لقاح كورونا
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States
لقاح كورونا
Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers
لقاح كورونا
Centers for Disease Control and Prevention
What to expect after getting a COVID-19 vaccine Vaccination considerations for persons with underlying medication conditions
Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U Benefits of getting a COVID-19 vaccine

تعرَّف على الحقائق بخصوص لقاحات كوفيد 19

COVID-19 vaccines and allergic reactions.

20
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
Centers for Disease Control and Prevention
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
Moderna COVID-19 vaccine: Fact sheet for recipients and caregivers
الأسئلة الشائعة حول لقاح كورونا (كوفيد١٩)
FDA for emergency use authorization